Alison Cooper

Medicine & Life Sciences

1. SMP-300 100%
2. Receptors, Serotonin, 5-HT3 98%
3. 3-benzenesulfonyl-8-piperazin-1-ylquinoline 87%
4. Neurons 80%
5. Globus Pallidus 79%
6. Receptor, Serotonin, 5-HT2C 74%
7. lorcaserin 71%
8. Dopamine 70%
9. Subthalamic Nucleus 70%
10. HU 211 69%
11. serotonin 6 receptor 69%
12. sibutramine 63%
13. Pharmacology 62%
14. Serotonin 5-HT2 Receptor Agonists 61%
15. Substantia Nigra 59%
16. pembrolizumab 58%
17. Orphaned Children 58%
18. Cannabinoid Receptor Agonists 57%
19. Ligand-Gated Ion Channels 56%
20. Calbindin 2 56%
21. Calbindins 55%
22. indole 54%
23. Inhibitory Postsynaptic Potentials 53%
24. In Vitro Techniques 52%
25. Calcium-Binding Proteins 51%
26. Dronabinol 51%
27. Feeding Behavior 50%
28. Dopamine D2 Receptors 49%
29. Irritable Bowel Syndrome 47%
30. Carcinoid Tumor 47%
31. Haloperidol 45%
32. Anorexia 44%
33. Interneurons 44%
34. Pars Reticulata 43%
35. Glycosylation 42%
36. gamma-Aminobutyric Acid 39%
37. Eating 39%
38. Gold Colloid 38%
39. Parvalbumins 35%
40. Food 29%
41. Serotonin 28%
42. Tardive Dyskinesia 27%
43. T-Lymphocytes 25%
44. Apoptosis 25%
45. Granisetron 24%
46. 6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline 24%
47. Interleukin-10 23%
48. Serotonin 5-HT3 Receptor Antagonists 22%
49. Pharmaceutical Preparations 22%
50. Quinpirole 21%